Random good picture Not show

(61) With the development of molecule biology and immunology, the immunotherapeutic means of leukemia have constantly increased.

(62) Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.

(63) Leukemic stem cell(LSC) is one of the main reasons of leukemia relapse.

(64) At present, the pathogenesy of leukemia is not very clear(sentencedict.com), which will achieve more recognition with the development of modern empirical method.

(65) The arctile makes review on the immunotherapeutic development of leukemia.

(66) Ganglioside GM3 has been proved to be a physiological cell differentiation inducer in several human leukemia cell lines. However, the inducing differentiation mechanism of GM3 remains unclear.

(67) Methods: The telomeric repeat amplification protocol ( TRAP ) combined with densitometry and clinical examination were performed in leukemia patients.

(68) Methods: Induction regiment of acute myeloid leukemia ( AML ) consisted of mitoxantrone and cytosine arabinoside ( Ara C ).

(69) Methods 16 mothers of children with leukemia were interviewed with open-ended questions. The data collected from the interviews were analyzed thematically .

(70) Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?

(71) We describe an 11-year-old boy with ureteropelvic obstruction secondary to pancreatitis following chemotherapy for acute lymphoblastic leukemia.

(72) Method: Studying of normal and sex chromosome by classic cytogenetic analyse in leukemia patients before and after treated by allo- HSCT.

(73) Background: A diagnosis of chronic lymphocytic leukemia (CLL) requires a count of over 5000 circulating CLL-phenotype cells per cubic millimeter.

(74) Objective To study the cross-lineage expression of acute lymphoblastic leukemia(ALL) with the use of multi-parameter flow cytometry in the immunophenotype of ALL.

(75) A large human phage antibody library was subjected for panning with leukocytes from healthy donors and leukemia patients to select for specific antibodies against leukocytic surface proteins.

(76) Object:To evaluate the prognostic impact of trisomy 8 on cytobiological and clinical features in acute myelomonocytic and monocytic leukemia (M4, M5).

(77) Objective To investigate the characteristics of immunophenotype of B chronic lymphocytic leukemia(B-CLL) and to evaluate the value of ZAP-70 and CD38 in diagnosis and prognosis of B-CLL.

(78) It has been reported in association with acute myeloid leukemia, myeloproliferative disorders, and myelodysplasia in blast transformation, as well as in patients with no known hematological disorders.

(79) Objective To establish human acute promyelocytic leukemia HL-60 model in severe combined immunodeficient (SCID) mice and to study the biological behaviors of HL-60 cell in SCID mice.

(80) Very low gamma globulins are a frequent feature of chronic lymphocytic leukemia.

(81) The stem cell leukemia ( SCL ) gene is a new oncogene related with leukemogenesis.

(82) Objective To investigate the apoptosis of human leukemia cell line HL-60 induced by Panax Notoginseng Saponins(PNS)and its mechanism.

(83) Objective To investigation the cytogenetic characteristic of the childhood acute mye logenous leukemia ( AML ).

(84) Objective It is to study the characteristic of immunophenotype in adult acute lymphoblastic leukemia(B-ALL) and its clinic meaning in detecting minimal residual diseases(MRD).

(85) The one of long-term effects of irradiation injury is leukemia. The bone marrow cells(BMC)transplantation including stem cells is the only effective therapy for acute radiation syndrome patients.

(86) Objective To investigate clinical features and management of disseminated intravascular coagulation ( DIC ) in patients with acute leukemia ( AL ).

(87) The cellular procoagulant activity(CPA) of the intact and lysed leukemic cells was evaluated in 34 cases of acute leukemia.

(88) Leukemia is a malignant hematopoietic system, is the most common malignant one.

(89) Imatinib is currently the most popular therapy for chronic myeloid leukemia ( CML ).

(90) This study was conducted to establish a L615 mouse minimal residual leukemia model and examine the effect of calcium leucovorin (LV) on minimal residual leukemia (MRL).